2-Amino-3-(4-chloro-1-methyl-1H-pyrazol-3-yl)propanoic acid hydrochloride

Catalog No.: 
ACTCOR525
CAS No.: 
1432026-01-1
Molecular Formula: 
C7H11Cl2N3O2
Molecular Weight: 
240.09
2-Amino-3-(4-chloro-1-methyl-1H-pyrazol-3-yl)propanoic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$211.00InquiryInquiry
100mg98%$304.00InquiryInquiry
250mg98%$426.00InquiryInquiry
1g98%$448.00InquiryInquiry
5g98%$2195.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-3-(4-chloro-1-methyl-1H-pyrazol-3-yl)propanoic acid hydrochloride
IUPAC Name2-amino-3-(4-chloro-1-methyl-1H-pyrazol-3-yl)propanoic acid hydrochloride
MDL No.MFCD25371131
Molecular FormulaC7H11Cl2N3O2
Molecular Weight240.09
SMILESO=C(O)C(N)CC1=NN(C)C=C1Cl.[H]Cl
InChI KeyNONNXTRNMRQAHN-UHFFFAOYSA-N
Synonym3-(4-chloro-1-methyl-1H-pyrazol-3-yl)alanine;2-amino-3-(4-chloro-1-methyl-1H-pyrazol-3-yl)propanoic acid hydrochloride
CAS No.1432026-01-1

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTCOR525 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTCOR525 route product structure diagram
    ACTCOR5251432026-01-1
Inquiry

2. ACTCOR525 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTCOR525 route product structure diagram
    ACTCOR5251432026-01-1
Inquiry

3. ACTCOR525 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTCOR525 route product structure diagram
    ACTCOR5251432026-01-1
Inquiry

Comments (0)